- Home
- QURE vs AMAL Comparison
QURE vs AMAL Comparison
Compare QURE & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | AMAL |
|---|---|---|
| Founded | 1998 | 1923 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | QURE | AMAL |
|---|---|---|
| Price | $47.51 | $46.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 2 |
| Target Price | ★ $45.00 | $36.00 |
| AVG Volume (30 Days) | ★ 2.6M | 109.3K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ 0.84 |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $21.18 |
| Revenue Next Year | $200.43 | $6.55 |
| P/E Ratio | ★ N/A | $54.52 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $25.13 |
| 52 Week High | $71.50 | $46.05 |
Technical Indicators
Market Signals| Indicator | QURE | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 73.18 | 63.71 |
| Support Level | $21.63 | $42.74 |
| Resistance Level | $60.70 | N/A |
| Average True Range (ATR) | 2.85 | 0.99 |
| MACD | 1.76 | 0.18 |
| Stochastic Oscillator | 87.87 | 78.96 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.